Resultados da busca - David Perol

Enhancing confidence in complex health technology assessments by using real-world evidence: highlighting existing strategies for effective drug evaluation por Alison Antoine, Katia Desroziers, Julien Dupin, David Pérol, Rémy Choquet

Obter o texto integral

Using numerical modeling and simulation to assess the ethical burden in clinical trials and how it relates to the proportion of responders in a trial sample. por Jean-Pierre Boissel, David Pérol, Hervé Décousus, Ingrid Klingmann, Marc Hommel

Obter o texto integral

Cicaderma® in radiation–related dermatitis of breast cancer: Results from the multicentric randomised phase III CICA-RT por Séverine Racadot, Antoine Arnaud, Camille Schiffler, Séverine Metzger, David Pérol, Youlia Kirova

Obter o texto integral

First clinical experience of intra-operative high intensity focused ultrasound in patients with colorectal liver metastases: a phase I-IIa study. por Aurélien Dupré, David Melodelima, David Pérol, Yao Chen, Jérémy Vincenot, Jean-Yves Chapelon, Michel Rivoire

Obter o texto integral

Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research project. por Monia Ezzalfani, Raphaël Porcher, Alexia Savignoni, Suzette Delaloge, Thomas Filleron, Mathieu Robain, David Pérol, ESME Group

Obter o texto integral

A multicentric, single arm, open-label, phase I/II study evaluating PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer (PRadR) por David Kryza, Armelle Vinceneux, Anne-Sophie Bidaux, Gwenaelle Garin, Delphine Tatu, Claire Cropet, Jean-Noël Badel, David Perol, Anne-Laure Giraudet

Obter o texto integral

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors por Sylvie Négrier, David Pérol, Rastislav Bahleda, Antoine Hollebecque, Etienne Chatelut, Helen Boyle, Philippe Cassier, Séverine Metzger, Ellen Blanc, Jean-Charles Soria, Bernard Escudier

Obter o texto integral

The French multicentric molecular analysis platforms and personalized medicine trials MOST, MOST Plus and MEGAMOST por Loic Verlingue, Marine Desevre, Marie Polito, Gwenaelle Garin, Christine Rodriguez, Wang Qing, Olivier Tredan, David Perol, Isabelle Ray-Coquard, Sylvie Chabaud, Jean Yves Blay

Obter o texto integral

Personalized Reimbursement Model (PRM) program: A real-world data platform of cancer drugs use to improve and personalize drug pricing and reimbursement in France. por Pierre-Alexandre Squara, Vinh-Phuc Luu, David Pérol, Bruno Coudert, Valérie Machuron, Camille Bachot, Laurence Samelson, Virginie Florentin, Jean-Marc Pinguet, Béchir Ben Hadj Yahia

Obter o texto integral

Toward Improved Diagnosis Accuracy and Treatment of Children, Adolescents, and Young Adults With Ependymoma: The International SIOP Ependymoma II Protocol por Pierre Leblond, Maura Massimino, Martin English, Timothy A. Ritzmann, Lorenza Gandola, Gabriele Calaminus, Sophie Thomas, Sophie Thomas, David Pérol, Julien Gautier, Richard G. Grundy, Didier Frappaz

Obter o texto integral

Therapeutic relevance of molecular screening program in patients with metastatic sarcoma: Analysis from the ProfiLER 01 trial por Patrick Arnaud-Coffin, Mehdi Brahmi, Hélène Vanacker, Lauriane Eberst, Olivier Tredan, Valery Attignon, Daniel Pissaloux, Emilie Sohier, Philippe Cassier, Gwenaelle Garin, David Pérol, Jean-Yves Blay, Armelle Dufresne

Obter o texto integral

Connected device and therapeutic patient education to promote physical activity among women with localised breast cancer (DISCO trial): protocol for a multicentre 2×2 factorial ran... por David Pérol, Jean-Baptiste Fassier, Tanguy Leroy, Marie Préau, Béatrice Fervers, Baptiste Fournier, Olivia Pérol, Aurélia Maire, Lidia Delrieu, Marina Touillaud, Elodie Belladame, Lionel Perrier, Florie Fillol, Sébastien Pascal, Thierry Durand

Obter o texto integral

Design and methods of a national, multicenter, randomized and controlled trial to assess the efficacy of a physical activity program to improve health-related quality of life and r... por Lidia Delrieu, Amélie Anota, Olivier Trédan, Damien Freyssenet, Aurélia Maire, Brice Canada, Baptiste Fournier, Olivia Febvey-Combes, Frank Pilleul, Amine Bouhamama, Christophe Caux, Florence Joly, Béatrice Fervers, Vincent Pialoux, David Pérol, Olivia Pérol

Obter o texto integral

Added value of whole‐exome and RNA sequencing in advanced and refractory cancer patients with no molecular‐based treatment recommendation based on a 90‐gene panel por Armelle Dufresne, Valéry Attignon, Anthony Ferrari, Laurie Tonon, Sandrine Boyault, Séverine Tabone‐Eglinger, Philippe Cassier, Olivier Trédan, Nadège Corradini, Armelle Vinceneux, Aurélie Swalduz, Alain Viari, Sylvie Chabaud, David Pérol, Jean Yves Blay, Pierre Saintigny

Obter o texto integral

Long term term follow-up of tyrosine kinase inhibitors treatments in inoperable or relapsing diffuse type tenosynovial giant cell tumors (dTGCT). por Mehdi Brahmi, Philippe Cassier, Armelle Dufresne, Sylvie Chabaud, Marie Karanian, Alexandra Meurgey, Amine Bouhamama, Francois Gouin, Gualter Vaz, Jerome Garret, Marie-Pierre Sunyach, Aurélien Dupré, Perrine Marec-Berard, Nadège Corradini, David Perol, Isabelle Ray-Coquard, Jean-Yves Blay

Obter o texto integral

Systematic referral to palliative care in patients attending dedicated emergency units from French comprehensive anticancer centres: the prospective multicentre randomised comparat... por David Pérol, Christine Mateus, Amélie Anota, Muriel Thomaso, Carole Bouleuc, Marie-Ange Massiani, Véronique Christophe, Lionel Perrier, Gisele Chvetzoff, Julien Gautier, Pauline Moreau, Gwendoline Le Divenah, Aline Henry, Marie François, Mansouria Merad, Laurie Bissuel, Anne-Sophie Baudry, Bruno Russias

Obter o texto integral

Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case Report por Romain Varnier, Thibaut Garrivier, Emilie Hafliger, Aymeric Favre, Clélia Coutzac, Clément Spire, Pauline Rochefort, Matthieu Sarabi, Françoise Desseigne, Pierre Guibert, Anne Cattey-Javouhey, Pamela Funk-Debleds, Charles Mastier, Adrien Buisson, David Pérol, Oliver Trédan, Jean-Yves Blay, Jean-Marc Phelip, Christelle de la Fouchardiere

Obter o texto integral

Precision medicine for patients with gastro-oesophageal cancer: A subset analysis of the ProfiLER program por Philippe A. Cassier, Clémentine Peyramaure, Valery Attignon, Lauriane Eberst, Camille Pacaud, Sandrine Boyault, Françoise Desseigne, Mathieu Sarabi, Pierre Guibert, Pauline Rochefort, Nathalie Marques, Michel Rivoire, Aurélien Dupré, Patrice Peyrat, Catherine Terret, Isabelle Ray-Coquard, Clélia Coutzac, David Pérol, Jean-Yves Blay, Olivier Trédan, Christelle de la Fouchardière

Obter o texto integral

Ribosome biogenesis‐based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VI... por Nour‐El‐Houda Mourksi, Cécile Dalban, Amélie Colombe‐Vermorel, Laetitia Odeyer, Valentin Simioni, Jean‐Sébastien Frenel, Michel Fabbro, Fernando Bazan, Sophie Abadie‐Lacourtoisie, Elodie Coquan, Séverine Martinez, Gwenaelle Garin, Séverine Tabone‐Eglinger, Isabelle Treilleux, Sylvie Chabaud, David Pérol, Isabelle Ray‐Coquard, Pierre‐Etienne Heudel, Jean‐Jacques Diaz, Virginie Marcel

Obter o texto integral

Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemothe... por Olivier Trédan, Delphine Loirat, Sylvie Chabaud, Philippe Toussaint, Thierry Petit, Frédéric Viret, Christelle Levy, Aurélien Robert, Julien Grenier, Laura Mansi, Jean-Philippe Spano, Anne Patsouris, Olfa Derbel, Christelle Jouannaud, Jean Marc Ferrero, Jean Sébastien Frenel, Yann Molin, Louis Doublet, Pierre-Etienne Heudel, Jean-Yves Pierga, Gwenaële Garin, David Pérol, Thomas Bachelot

Obter o texto integral